Clinical Trials Browser

INDUSTRY × Multi-centric Castleman's Disease × siltuximab × Clear all

NCT01024036 2018-03-21

A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease

Phase 2 Completed

79 enrolled 20 charts

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Neoplasms